Insulin contract renewal likely for Duopharma Biotech – The Edge Markets MY
Insulin contract renewal likely for Duopharma Biotech The Edge Markets MY
Duopharma Biotech Bhd (Sept 6, RM1.37) Buy with a higher target price (TP) of RM1.70 (from RM1.62): On government tenders and Pharmaniaga Bhd’s …
Source: Financial New feed